Literature DB >> 19225860

A beneficial effect of 3-year spironolactone therapy supplementing atenolol therapy on the remodeling of atria and ventricles in a patient with permanent atrial fibrillation.

Rafał Dabrowski, Cezary Sosnowski, Ewa Michalak, Hanna Szwed.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19225860     DOI: 10.1007/s11739-009-0229-4

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  5 in total

Review 1.  Aldosterone: cardiovascular assault.

Authors:  Allan D Struthers
Journal:  Am Heart J       Date:  2002-11       Impact factor: 4.749

2.  Atrial remodeling in persistent atrial fibrillation: the potential role of aldosterone.

Authors:  Panagiotis Korantzopoulos; Theofilos Kolettis; Evaggelos Kountouris; Konstantinos Siogas
Journal:  Eur Heart J       Date:  2004-06       Impact factor: 29.983

3.  Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.

Authors:  Jeff S Healey; Adrian Baranchuk; Eugene Crystal; Carlos A Morillo; Michael Garfinkle; Salim Yusuf; Stuart J Connolly
Journal:  J Am Coll Cardiol       Date:  2005-06-07       Impact factor: 24.094

4.  Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study.

Authors:  A J Sanfilippo; V M Abascal; M Sheehan; L B Oertel; P Harrigan; R A Hughes; A E Weyman
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

Review 5.  Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation.

Authors:  Grace Casaclang-Verzosa; Bernard J Gersh; Teresa S M Tsang
Journal:  J Am Coll Cardiol       Date:  2008-01-01       Impact factor: 24.094

  5 in total
  1 in total

Review 1.  Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling.

Authors:  Fadia Mayyas; Karem H Alzoubi; David R Van Wagoner
Journal:  Int J Cardiol       Date:  2013-08-15       Impact factor: 4.164

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.